142 related articles for article (PubMed ID: 38078335)
1. Opinion paper: effectiveness of sirolimus in treating partial Di George syndrome with autoimmune lymphoproliferative syndrome-like features.
van der Werff Ten Bosch J
Front Pediatr; 2023; 11():1242652. PubMed ID: 38078335
[TBL] [Abstract][Full Text] [Related]
2. Case report: Effectiveness of sirolimus in treating partial DiGeorge Syndrome with Autoimmune Lymphoproliferative Syndrome (ALPS)-like features.
Gu H; Mou W; Chen Z; Xie X; Yao J; Zhang R; Wu R; Gui J
Front Pediatr; 2022; 10():1014249. PubMed ID: 36741091
[TBL] [Abstract][Full Text] [Related]
3. Use of Sirolimus (Rapamycin) for Treatment of Cytopenias and Lymphoproliferation Linked to Autoimmune Lymphoproliferative Syndrome (ALPS). Two Case Reports.
Cayrol J; Garrido Colino C
J Pediatr Hematol Oncol; 2017 May; 39(4):e187-e190. PubMed ID: 28234735
[TBL] [Abstract][Full Text] [Related]
4. [Microdeletion 22q11: apropos of case of schizophrenia in an adolescent].
Pinquier C; Héron D; de Carvalho W; Lazar G; Mazet P; Cohen D
Encephale; 2001; 27(1):45-50. PubMed ID: 11294038
[TBL] [Abstract][Full Text] [Related]
5. Case report: Effectiveness of sirolimus in a
Gu H; Chen Z; Ma J; Ma J; Fu L; Zhang R; Wang T; Wu R
Front Pediatr; 2022; 10():868193. PubMed ID: 35967554
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune Lymphoproliferative Syndrome-FAS Patients Have an Abnormal Regulatory T Cell (Treg) Phenotype but Display Normal Natural Treg-Suppressive Function on T Cell Proliferation.
Mazerolles F; Stolzenberg MC; Pelle O; Picard C; Neven B; Fischer A; Magerus-Chatinet A; Rieux-Laucat F
Front Immunol; 2018; 9():718. PubMed ID: 29686686
[TBL] [Abstract][Full Text] [Related]
7. Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management.
López-Nevado M; González-Granado LI; Ruiz-García R; Pleguezuelo D; Cabrera-Marante O; Salmón N; Blanco-Lobo P; Domínguez-Pinilla N; Rodríguez-Pena R; Sebastián E; Cruz-Rojo J; Olbrich P; Ruiz-Contreras J; Paz-Artal E; Neth O; Allende LM
Front Immunol; 2021; 12():671755. PubMed ID: 34447369
[TBL] [Abstract][Full Text] [Related]
8. Low thymic output, peripheral homeostasis deregulation, and hastened regulatory T cells differentiation in children with 22q11.2 deletion syndrome.
Ferrando-Martínez S; Lorente R; Gurbindo D; De José MI; Leal M; Muñoz-Fernández MA; Correa-Rocha R
J Pediatr; 2014 Apr; 164(4):882-9. PubMed ID: 24461789
[TBL] [Abstract][Full Text] [Related]
9. Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome.
McLean-Tooke A; Spickett GP; Gennery AR
Scand J Immunol; 2007 Jul; 66(1):1-7. PubMed ID: 17587340
[TBL] [Abstract][Full Text] [Related]
10. Optimal Management of Autoimmune Lymphoproliferative Syndrome in Children.
George LA; Teachey DT
Paediatr Drugs; 2016 Aug; 18(4):261-72. PubMed ID: 27139496
[TBL] [Abstract][Full Text] [Related]
11. Lack of correlation between impaired T cell production, immunodeficiency, and other phenotypic features in chromosome 22q11.2 deletion syndromes.
Sullivan KE; Jawad AF; Randall P; Driscoll DA; Emanuel BS; McDonald-McGinn DM; Zackai EH
Clin Immunol Immunopathol; 1998 Feb; 86(2):141-6. PubMed ID: 9473376
[TBL] [Abstract][Full Text] [Related]
12. A Spectrum of Clinical Findings from ALPS to CVID: Several Novel LRBA Defects.
Cagdas D; Halaçlı SO; Tan Ç; Lo B; Çetinkaya PG; Esenboğa S; Karaatmaca B; Matthews H; Balcı-Hayta B; Arıkoğlu T; Ezgü F; Aladağ E; Saltık-Temizel İN; Demir H; Kuşkonmaz B; Okur V; Gümrük F; Göker H; Çetinkaya D; Boztuğ K; Lenardo M; Sanal Ö; Tezcan İ
J Clin Immunol; 2019 Oct; 39(7):726-738. PubMed ID: 31432443
[TBL] [Abstract][Full Text] [Related]
13. [Endocrine complications in primary immunodeficiency diseases].
Halász Z
Orv Hetil; 2018 Dec; 159(49):2065-2072. PubMed ID: 30525884
[TBL] [Abstract][Full Text] [Related]
14. Understanding the Spectrum of Immune Dysregulation Manifestations in Autoimmune Lymphoproliferative Syndrome and Autoimmune Lymphoproliferative Syndrome-like Disorders.
Failing C; Blase JR; Walkovich K
Rheum Dis Clin North Am; 2023 Nov; 49(4):841-860. PubMed ID: 37821199
[TBL] [Abstract][Full Text] [Related]
15. Persistent low thymic activity and non-cardiac mortality in children with chromosome 22q11.2 microdeletion and partial DiGeorge syndrome.
Eberle P; Berger C; Junge S; Dougoud S; Büchel EV; Riegel M; Schinzel A; Seger R; Güngör T
Clin Exp Immunol; 2009 Feb; 155(2):189-98. PubMed ID: 19040613
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Autoimmune Thyroid Disease in a Cohort of 73 Paediatric Patients Affected by 22q11.2 Deletion Syndrome: Longitudinal Single-Centre Study.
Ricci S; Sarli WM; Lodi L; Canessa C; Lippi F; Azzari C; Stagi S
Genes (Basel); 2022 Aug; 13(9):. PubMed ID: 36140720
[TBL] [Abstract][Full Text] [Related]
17. Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity.
Fuss IJ; Strober W; Dale JK; Fritz S; Pearlstein GR; Puck JM; Lenardo MJ; Straus SE
J Immunol; 1997 Feb; 158(4):1912-8. PubMed ID: 9029133
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).
Teachey DT; Obzut DA; Axsom K; Choi JK; Goldsmith KC; Hall J; Hulitt J; Manno CS; Maris JM; Rhodin N; Sullivan KE; Brown VI; Grupp SA
Blood; 2006 Sep; 108(6):1965-71. PubMed ID: 16757690
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Follow-Up of Newborns with 22q11 Deletion Syndrome and Low TRECs.
Framme JL; Lundqvist C; Lundell AC; van Schouwenburg PA; Lemarquis AL; Thörn K; Lindgren S; Gudmundsdottir J; Lundberg V; Degerman S; Zetterström RH; Borte S; Hammarström L; Telemo E; Hultdin M; van der Burg M; Fasth A; Oskarsdóttir S; Ekwall O
J Clin Immunol; 2022 Apr; 42(3):618-633. PubMed ID: 35080750
[TBL] [Abstract][Full Text] [Related]
20. Case report: Neonatal autoimmune lymphoproliferative syndrome with a novel pathogenic homozygous
Elgharbawy FM; Karim MY; Soliman DS; Hassan AS; Sudarsanan A; Gad A
Front Pediatr; 2023; 11():1150179. PubMed ID: 37152306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
